主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LNSR
#3130
LENSAR, Inc. Common Stock
11.9
7
-0.66%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.66%
每月变动
-3.86%
6个月变化
-1.89%
年变化
+7.55%
前一天收盘价
12.0
5
Open
11.9
7
Bid
Ask
Low
11.9
7
High
11.9
7
交易量
17
市场
股票
医疗保健
LNSR
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
TTM
Cash from operating activities
13.79 M
8.97 M
14.86 M
9.66 M
2.27 M
11.79 M
Cash from investing activities
326 K
354 K
115 K
4.16 M
2.16 M
969 K
Cash from financing activities
50 M
361 K
1.99 M
19.76 M
78 K
9.77 M
Free cash flow
13.43 M
8.62 M
14.74 M
9.42 M
2.12 M
11.71 M
新闻
LENSAR与Alcon交易完成时间推迟至2026年上半年
LENSAR-Alcon deal closing pushed to first half of 2026
Lensar: Timing And Arbitrage Considerations In Alcon's Acquisition Bid (NASDAQ:LNSR)
LENSARQ3每股收益及营收逊于预期
LENSAR earnings missed by $0.26, revenue fell short of estimates
LENSAR earnings missed by $0.08, revenue fell short of estimates
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019 - Alcon (NYSE:ALC)
Alcon: A Clear Vision, But Fully Valued (NYSE:ALC)
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - LENSAR (NASDAQ:LNSR), Alcon (NYSE:ALC)
LENSAR stock surges 23.7% as Q4 revenue beats estimates